Innate Pharma (NASDAQ:IPHA) outlined progress across its prioritized oncology pipeline and reviewed full-year 2025 financial results, emphasizing a streamlined strategy centered on three clinical ...
Sarepta Therapeutics (NASDAQ:SRPT) presented preliminary clinical data from ongoing phase I/II studies of two investigational ...
Barchart on MSN
Netflix could be setting up for a big show, but I’m not convinced the move will be up. Here’s why.
Many of us have learned more about the Strait of Hormuz in the past month than we ever expected to learn in a decade. It is a necessary part of comprehending the current stock market environment. And ...
Is They Will Kill You worth watching? Expert review covering plot, psychological depth, strengths, and why this horror film stands out in 2026.
As the low carbon transition of power systems accelerates, low carbon demand response, characterized by both environmental orientation and behavioral incentives, has become a key mechanism for ...
The field of biosensor technology is undergoing rapid transformation, driven by the need for precise, real-time monitoring of biochemical processes such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results